Asset Details
Do you wish to reserve the book?
Robot-assisted functional minimally invasive radical resection of esophageal cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Robot-assisted functional minimally invasive radical resection of esophageal cancer
Do you wish to request the book?
Robot-assisted functional minimally invasive radical resection of esophageal cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Robot-assisted functional minimally invasive radical resection of esophageal cancer
2025
Overview
Background
Recently, robot-assisted surgical systems have become more and more popular, but have not been reported in functional minimally invasive radical resection of esophageal cancer,which preserves the mediastinal pleura, the azygos arch, bronchial artery, and pulmonary branch of the vagus nerve.
Methods
Retrospective analysis of all patients in our hospital who underwent surgery for esophageal cancer from September 2022 to February 2024. Robot-assisted functional minimally invasive esophagectomy (RAFMIE)was performed for 44 patients who were compared with 66 functional minimally invasive esophagectomy (FMIE) cases.
Result
Significantly, shorter operation time was taken in RAFMIE (222.98 ± 28.02 vs 250.45 ± 30.25 min
P
< 0.001), thoracic operation time (75.50 ± 14.23 vs 89.59 ± 16.34 min
P
< 0.001), abdominal operation time (51.93 ± 14.18 vs 71.75 ± 14.85 min
P
< 0.001). Both groups were equal regarding intraoperative blood loss (82.73 ± 57.23 vs 94.55 ± 60.19 ml,
P
= 0.286), radical resection (R0) rate (97.73% vs 96.97%,
P
= 0.813) and total lymph node yield (25.45 ± 7.40 vs 21.03 ± 7.00,
P
= 0.013). Postoperative hospital stay (9.75 ± 2.23 vs 10.47 ± 2.72,
P
= 0.402); incidence of postoperative complications (25.76% vs 20.45%,
P
= 0.519).
Conclusion
Early results suggest that RAFMIE is safe and feasible for the treatment of esophageal cancer. The operation time of RAFMIE is shorter than FMIE, and the lymph node dissection results are better. Long-term results need to be further investigated.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Aged
/ Cancer
/ Consent
/ Current Evidence and Future Directions in the Treatment of Colorectal Cancer
/ Diabetes
/ Esophageal Neoplasms - pathology
/ Esophageal Neoplasms - surgery
/ Esophagectomy - adverse effects
/ Female
/ Gender
/ Humans
/ Length of Stay - statistics & numerical data
/ Lymph Node Excision - methods
/ Male
/ Medicine
/ Methods
/ Minimally Invasive Surgical Procedures - methods
/ Patients
/ Pleura
/ Postoperative Complications - epidemiology
/ Postoperative Complications - etiology
/ Robot-assisted functional minimally invasive esophagectomy (RAFMIE)
/ Robot-assisted surgical systems
/ Robotic Surgical Procedures - adverse effects
/ Robotic Surgical Procedures - methods
/ Robotics
/ Robots
/ Surgeons
/ Surgery
/ Thorax
/ Tumors
